Breaking News Instant updates and real-time market news.

CVS

CVS Health

$63.41

-0.59 (-0.92%)

, AET

Aetna

$173.40

0.12 (0.07%)

10:31
04/13/18
04/13
10:31
04/13/18
10:31

CVS hires new chief medical officer for MinuteClinics, CNBC reports

CVS Health (CVS), which is in the process of acquiring health insurer Aetna (AET), has hired Marc-David Munk away from Iora Health to be chief medical officer for the chain's MinuteClinic walk-in clinics business, according to CNBC. Reference Link

CVS

CVS Health

$63.41

-0.59 (-0.92%)

AET

Aetna

$173.40

0.12 (0.07%)

  • 16

    Apr

  • 30

    May

CVS CVS Health
$63.41

-0.59 (-0.92%)

04/02/18
LEER
04/02/18
NO CHANGE
LEER
Possible Humana/Walmart deal transformational for U.S. seniors market, says Leerink
Leerink analyst Ana Gupte sees the possible Humana (HUM)-Walmart (WMT) deal as transformational for the U.S. Seniors market and estimates the deal value at close to $50B. The analyst also believes the deal helps Humana compete more effectively with UnitedHealth (UNH)/Optum and Aetna (AET)-CVS (CVS), while Walmart can also compete with Amazon (AMZN) that is eroding sales and likely eyeing an entry into the Prescription Rx market. Gupte expects the anti-trust scrutiny of three deals Aetna-CVS, Cigna (CI)-Express Scripts (ESRX) and Humana-Walmart by the DOJ will be more challenged under simultaneous review by the DOJ, though Walmart and Humana have the least anti-competitive issues. Humana-Walmart could catalyze a counter-offer for Cigna from Walgreens Boots Alliance (WBA) or even Amazon, or re-invigorate Walgreens-AmerisourceBergen (ABC) talks, she contends.
04/02/18
MSCO
04/02/18
NO CHANGE
MSCO
Equal Weight
Morgan Stanley says may make sense for Walmart to play bigger role in healthcare
Morgan Stanley analyst Simeon Gutman estimates Walmart (WMT) generates about $20B in pharmacy sales annually, which he believes makes it the third largest U.S. pharmacy provider behind CVS (CVS) and Walgreens (WBA). Following a report from The Wall Street Journal that the company and Humana (HUM) were in merger talks, and subsequent reports from Reuters and Bloomberg that the two may only be discussing a broader partnership instead of a buyout deal, Gutman said that consolidation of other retailers and healthcare providers could put Walmart at a disadvantage and he believes it may make sense for Walmart to play a larger role in healthcare. He maintains an Equal Weight rating on Walmart shares.
04/05/18
CHLM
04/05/18
NO CHANGE
Target $30
CHLM
Hold
CVS focusing on home dialysis positive for NxStage Medical, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich notes that CVS Health (CVS) announced an initiative to improve patient outcomes for chronic kidney disease and dialysis. The analyst believes that a company of CVS Health's size and stature focusing on home dialysis and specifically home hemodialysis is a positive for NxStage Medical (NXTM) since it is the market leader with a huge head start. While there could be concerns about price competition if and when CVS Health is able to get a home hemodialysis device to market, NxStage Medical will have its next generation products to market, as well as a peritoneal dialysis machine, he contends, adding that he thinks the market opportunity will be much larger. Ellich reiterates a Hold rating and $30 price target on NxStage Medical's shares.
04/10/18
LEER
04/10/18
NO CHANGE
Target $85
LEER
Outperform
CVS drug trend report highlights value of PBM model, says Leerink
Leerink analyst David Larsen notes that CVS recently published its 2017 drug trend report, and reported good performance, posting total drug trend of +1.9%. In his view, this trend which is a five-year low, and the 0.2% reported drug price growth, is evidence that the PBM business model delivers significant value to clients. The analyst is generally positive on the PBM business model, and despite constant "noise" around transparency and drug costs, he believes the proof is in the trend. Larsen reiterates an Outperform rating and $85 price target on the shares.
AET Aetna
$173.40

0.12 (0.07%)

02/01/18
02/01/18
DOWNGRADE
Target $69

Underperform
Express Scripts downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Lance Wilkes downgraded Express Scripts to Underperform from Market Perform, with a $69 price target, as he believes tax reform is fully price in and his original concerns on the standalone PBM model remain. Further, the analyst sees additional risks from a potential CVS (CVS)/Aetna (AET) merger and Amazon (AMZN) threats.
04/03/18
RBCM
04/03/18
NO CHANGE
RBCM
Final Medicare Advantage rate better than expected, says RBC Capital
The Centers for Medicare and Medicaid Services' final notice for 2019 Medicare Advantage plans provides a 3.40% net increase in capitation rates and finalizes expanded coverage for non-skilled home health, along with other proposals, RBC analyst Frank Morgan tells investors in a research note. He believes the payment updates should be viewed positively for Managed Care stocks, and the expanded coverage of in-home services is a positive for Home Health stocks. Managed Care stocks include Aetna (AET), Anthem (ANTM), Humana (HUM) and UnitedHealth (UNH). Home Health stocks include LHC Group (LHCG) and Amedisys (AMED). Morgan notes that both companies have "built out significant personal care platforms."
04/11/18
WELS
04/11/18
NO CHANGE
WELS
Centene contract win in Pennsylvania looks set to be rebid, says Wells Fargo
Wells Fargo analyst Peter Costa said he believes the Pennsylvania Commonwealth Court ruled on the side of UnitedHealth (UNH) that the state Department of Human Services violated the state's procurement code when it had previously awarded a Medicaid contract to Centene (CNC). Given this ruling, Costa thinks the state will have to start the procurement process for the third time. He views the court ruling as a modest positive for UnitedHealth and Aetna (AET) and a modest negative for Centene (CNC), though he also noted that this win was not in Centene's 2018 guidance. Costa has Outperform ratings on all three stocks mentioned.

TODAY'S FREE FLY STORIES

GLD

SPDR Gold Trust

$115.95

0.71 (0.62%)

17:42
10/15/18
10/15
17:42
10/15/18
17:42
Hot Stocks
SPDR Gold Trust rise to 748.76MT from 744.64MT »

This is the 2nd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGC

India Globalization Capital

$5.30

0.35 (7.07%)

17:35
10/15/18
10/15
17:35
10/15/18
17:35
Syndicate
Breaking Syndicate news story on India Globalization Capital »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RWLK

ReWalk Robotics

$0.81

-0.0038 (-0.47%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Syndicate
Breaking Syndicate news story on ReWalk Robotics »

ReWalk Robotics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$123.59

0.12 (0.10%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Initiation
Zimmer Biomet initiated  »

Zimmer Biomet initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 26

    Oct

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Rio Tinto »

Rio Tinto sees Pilbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$249.10

0.64 (0.26%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Teleflex initiated  »

Teleflex initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Hot Stocks
Rio Tinto reports Q3 Pilbara iron ore output 82.5M tons, down 3% from last year »

Pilbara iron ore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYK

Stryker

$169.42

-1.66 (-0.97%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Stryker initiated  »

Stryker initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MDT

Medtronic

$93.81

-0.85 (-0.90%)

17:32
10/15/18
10/15
17:32
10/15/18
17:32
Initiation
Medtronic initiated  »

Medtronic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

17:31
10/15/18
10/15
17:31
10/15/18
17:31
Hot Stocks
Adobe says it is expanding creative cloud to non-professionals »

Says over the last few…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRC

Hill-Rom

$87.26

-1.04 (-1.18%)

17:30
10/15/18
10/15
17:30
10/15/18
17:30
Initiation
Hill-Rom initiated  »

Hill-Rom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

EW

Edwards Lifesciences

$141.95

-1.44 (-1.00%)

17:29
10/15/18
10/15
17:29
10/15/18
17:29
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CNMD

CONMED

$73.17

0.73 (1.01%)

17:28
10/15/18
10/15
17:28
10/15/18
17:28
Initiation
CONMED initiated  »

CONMED initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

17:27
10/15/18
10/15
17:27
10/15/18
17:27
Syndicate
Breaking Syndicate news story on T2 Biosystems »

T2 Biosystems files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.43

-0.56 (-1.51%)

17:26
10/15/18
10/15
17:26
10/15/18
17:26
Initiation
Boston Scientific initiated  »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BDX

Becton Dickinson

$238.38

-4.33 (-1.78%)

17:25
10/15/18
10/15
17:25
10/15/18
17:25
Initiation
Becton Dickinson initiated  »

Becton Dickinson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BAX

Baxter

$70.88

-0.39 (-0.55%)

17:24
10/15/18
10/15
17:24
10/15/18
17:24
Initiation
Baxter initiated  »

Baxter initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 31

    Oct

CRMD

CorMedix

$2.15

-0.12 (-5.29%)

17:23
10/15/18
10/15
17:23
10/15/18
17:23
Syndicate
Breaking Syndicate news story on CorMedix »

CorMedix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVNS

Avanos

$60.02

0.59 (0.99%)

17:22
10/15/18
10/15
17:22
10/15/18
17:22
Initiation
Avanos initiated  »

Avanos initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$68.72

-0.62 (-0.89%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Initiation
Abbott initiated  »

Abbott initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SBBX

SB One Bancorp

$24.00

-0.27 (-1.11%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Hot Stocks
Breaking Hot Stocks news story on SB One Bancorp »

EJF Capital reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:07
10/15/18
10/15
17:07
10/15/18
17:07
Hot Stocks
Hanwah Q Cells up 8.5% after agreeing to be acquired by Hanwha Solar »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.38

-0.005 (-0.36%)

17:06
10/15/18
10/15
17:06
10/15/18
17:06
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$30.64

0.42 (1.39%)

17:04
10/15/18
10/15
17:04
10/15/18
17:04
Earnings
CryoLife reports preliminary Q3 revenue $64.6M, consensus $61.84M »

Preliminary and unaudited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

, RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:03
10/15/18
10/15
17:03
10/15/18
17:03
Hot Stocks
Turquoise Hill provides underground development update »

Turquoise Hill (TRQ)…

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

RIO

Rio Tinto

$49.54

0.34 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.